Lab Members

Huai-Chin Chiang, Ph.D.

Huai-Chin Chiang received her Ph.D. in Molecular Medicine from University of Texas Health Science Center at San Antonio. Her research focus in Li Lab is to study the crosstalk between anti-tumor immunity and BRCA1 cancer biology.

Jorge Azpurua

Jorge Azpurua, Ph.D.

Jorge Azpurua received his Ph.D. in Biology from the University of Rochester in 2013 studying the tumor resistance and longevity determinants of non-model rodents under the mentorship of Andrei Seluanov and Vera Gorbunova. He has also studied motor neuron aging (Benjamin Eaton Laboratory, University of Texas Health Science Center at San Antonio) and ALS-related neurodegeneration (Joshua Dubnau Laboratory, Stony Brook University). His current work in the Li lab focuses on mechanisms of immune-exclusion and tumor progression in triple-negative breast cancer.

Mai Vu

Mai Vu, B.Sc.



Mai Vu is a master’s student in the Bioinformatics and Molecular Biochemistry program with a concentration in Molecular Biochemistry at George Washington University. She is currently working on her student research project focusing on BRCA1.

Weidong Chai

Weidong Chai, Ph.D.

Weidong Chai received his Ph.D. from Nanjing Medical University. His research focuses on the crosstalk of adipocytes in the breast tumor microenvironment and its role in tumor immunity.

Payal Mitra, Ph.D.

Payal completed her Ph.D. in Cell and Molecular Biology from NTU, Singapore. Her research focus in the Li Lab is to study the mechanistic role of tumor DDR1 in immune exclusion and explore the interplay of host and tumor DDR1 in regulation of carcinogenesis.

Zubaydah Alahmadi, MSc.

Zubaydah has completed her Master’s in Bioinformatics and Molecular Biochemistry from The George Washington University (GW). She defended her thesis on the Role of HDAC6i on the Alteration of CD47/SIRPa Pathway in Human Melanome at GW Cancer Center (GWCC). Currently, she is a senior research assistant in Dr. Rong Li’s lab and her research interests focus on the functional role of DDR1 in the progress of Breast Cancer.